The row between the UK and the EU over distribution of the AstraZeneca (AZ) vaccine turned bitter when the EU took “revenge” on AZ – and the UK – by vilifying the vaccine in a factually incorrect manner. Vaccines which usually take a decade to test and license were rolled out in a year or less under the intense pressure of the devastating covid19 pandemic, and with such haste small errors were inevitable. Enemies of the UK particularly their traditional ones in Europe took advantage of small mis-steps in clinical trial reporting to – without any rational basis – restrict the AZ vaccine to those younger than 55. AZ had out of safety concern restricted it’s initial rushed trial to under-55’s or safety reasons, this then being used against them.
As we all know, then the story of blood clots began to appear linked to the AZ jab. Apparently, we were told by scientists at the Paul Scherer Institute in Germany, a rare type of blood clot occured at a risk of a few per million with the AZ vaccine but not the other vaccines (Pfizer, Moderna). This as we shall see will turn out to be false – all the covid19 vaccines have a similar risk of deep brain blood clots. But these occured in younger people, mainly women, so the EU’s Blitzkrieg against AZ was forced to turn nimbly 180 degrees around. Now the vaccine was allowed for older patients (everyone by now realised that their initial reasoning that the AZ vaccine was ineffective in older people, so memorably articulated by Emmanual Macron, was false) – but the restriction now switched to the young. Now the under 55’s were barred from the AZ vaccine.
But hang on – I hear you say – we know that the Pfizer and Moderna (and also Russia’s Sputnik V) vaccines were about 90 percent effective, while that of AZ only about 70 %. Well yes – but those numbers came from the initial quick and quite small clinical trials of a few tens of thousands of patients. In these cases effectiveness was measured by the handful of cases developing covid19 during the study period. A single case more or less can change the percentage result by 10 percent or so. So these numbers are very approximate. Much better data would come later when the vaccines were rolled out to millions.
The vaccines have now been rolled out to tens of millions. What is strange is that still people use those initial rough guesses from the small clinical trials to define each drug’s effectiveness: Pfizer and Moderna 90%, AZ 70%. Pfizer have been successful in persuading Anthony Fauci, Pfizer’s lapdog in the USA’s FDA, to accept only the initial tiny clinical trial and ignore data from subsequent vaccine rollout.
But what is the vaccine rollout to tens of millions telling us – if we are interested? Firstly, the risk of those deep brain clots are only fractionally less in Pfizer’s and Moderna’s mRNA vaccines than in the AZ vaccine – the risk (in as yet unpublished data) is about 4 and 5 in a million respectively. This is an almost insignificant difference. Dozens of countries around the world have stopped AZ vaccine rollout for precisely nothing.
The report of the deep brain clot risk by the German Paul Scherer Institute was wrong on many levels. Even a low risk of clots would be significant if the vaccine was being rolled out in the absence of a virus epidemic. But – there would not really be any reason to vaccinate against nothing. The reason for the vaccines is that – in case you missed it – there is a covid19 pandemic killing millions of people. Now it turns out that blood clotting is one of the things that the covid19 virus does to its victims due to its effects on the innate archaic complement sector of the human immune system. (This is the element of covid19 susceptibility linked to Neanderthal-descended genes.) And the risk of exactly the same deep brain blood clots is up to a hundred times higher for covid19 infection than for vaccination. The Scherer Institute failed (deliberately) to factor into the risk analysis the covid19 pandemic itself. Any effectiveness of the vaccine against covid19, reducing infection numbers, will therefore reduce the number of deep brain clots. This will cancel out the tiny few-per-million risk of clots in the meaningless hypothetical case of a vaccine being given to people to protect them from nothing.
And when it comes to real world effectiveness in the tens-of-millions rollouts, it is turning out that the AZ adenovirus based vaccine is at least as effective as the Pfizer and Moderna mRNA vaccines, possibly more effective especially in the T-cell component of vacine protection.
Real data on the effectiveness of coronavirus vaccines given in the UK shows that while Pfizer vaccine is 85% effective against covid19 hospital admissions, the AstraZeneca vaccine is 94% effective. So in the real world the AZ vaccine is working better than the Pfizer vaccine. As well as costing nearly ten times less and not requiring minus 70-80 degrees expensive deep freeze storage.
The reduction in the risk of symptomatic infection in over-80s observed in early 2021 during ongoing UK vaccination of the population, is 57% and 63% respectively for the Pfizer and Oxford-AZ jabs, 14 days after a single dose. Again better results from the AZ vaccine.
Better T-cell protection with lasting and adaptive protection from AZ, not Pfizer
The British Medical Journal has published data showing the AZ and Pfizer vaccines have similar effectiveness at antibody production against covid19, but that AZ gives a better T-cell response:
“A single dose of the Pfizer or Oxford-AstraZeneca covid-19 vaccine produces equivalent antibody responses five weeks after vaccination, a small study looking at people over 80 has found.
The study, led by University of Birmingham researchers and made available through a preprint, found that antibodies specific to the SARS-CoV-2 spike protein were present in most people in both groups—93% after the Pfizer vaccine and 87% after the AstraZeneca vaccine.
The study also found stronger T cell responses in people who had received the AstraZeneca vaccine, with 31% of this group producing detectable T cell responses compared with 12% of the Pfizer-BioNTech vaccine group.
The difference between antibodies and T cells is that antibodies are seeing shapes, like a lock and a key, and therefore a single amino acid can make a big change in the structure, and that means a lot of antibodies can’t bind. Whereas T cells see little peptide fragments, the virus is stripped into fragments and therefore the T cell response is not so badly lost against single amino acid changes.”
Further problems with the Pfizer vaccine are coming to light. Dr. J. Patrick Whelan, a pediatric rheumatologist, tried to warn the Food and Drug Administration (FDA) in the USA back in December that mRNA injections have the potential to cause microvascular injury to the brain, heart, liver and kidneys – and in ways that were not even assessed during safety trials:
In his public submission, Whelan, a veteran physician with decades of experience in his field, alerted the FDA to these potential vaccine injuries, noting that the spike protein component of the jabs is a potential trigger for serious injuries.
Whelan explained that experimental mRNA technology has “the potential to cause microvascular injury (inflammation and small blood clots called microthrombi) to the brain, heart, liver and kidneys in ways that were not assessed in the safety trials.”
Whelan provided a plethora of evidence and pertinent information to back his warning, which the FDA patently ignored. Instead, the FDA chose to rely on very limited clinical trial data provided by the jabs’ manufacturers as “evidence” that they are “safe and effective” enough to warrant an EUA designation.
The very next day, in fact, the FDA issued an EUA to Pfizer-BioNTech, effectively slapping Whelan in the face, along with the rest of America. The FDA was dead-set on getting Donald Trump’s “Operation Warp Speed” injections distributed as quickly as possible, and nothing was going to get in the way of that.
So the overall picture is that:
- Deep brain clot risk is almost the same between AZ, Pfizer and Moderna and cancelled out by the protection against the much bigger risk of the same brain clots – the covid19 virus itself
- The AZ vaccine appears slightly more effective in population protection from covid19 than the Pfizer and Moderna vaccines. And there are indications that the T-cell component of vaccine protection could be 3 times stronger from the AZ vaccine than from the Pfizer one.
- Other risks of mRNA vaccines are being brushed under the carpet by the FDA where the relationship between Pfizer and the FDA is the same captive one as that in aviation between Boeing and the FAA, which led to the Boeing 737 Max disasters. American regulators are in the pockets of the biggest firms, and Pfizer is the world’s biggest pharma company.
A final observation. The EU authorized the export of 113.5 million doses to 43 countries between Jan. 31 and April 13, 2021, according to a memo circulated to government envoys in Brussels on Wednesday, Bloomberg reported. Around 39.2 million doses were shipped to Japan, 15.2 million to the U.K. and 11.7 million to Canada, according to the document.
If Japan received more than twice as many doses as the the UK, and Canada almost as many, why did the EU single out the UK only as being “selfish” for not sharing doses with the EU? Why not Japan or Canada? Curious minds want to know.
Every single element of the global lynching of AstraZeneca is built on nothing but lies. Gradually this fact will become clear to everyone.